Hepatitis C and Innate Immunity: Recent Advances
Authors:
- Gyongyi SzaboGSGyongyi Szabo
- Angela DolganiucADAngela Dolganiuc
- 1 August 2008
- journal article
- review article
- Published by Elsevier in Clinics in Liver Disease
- Vol. 12 (3) , 675-692
Abstract
No abstract availableKeywords
This publication has 116 references indexed in Scilit:
- Hepatitis C Virus Nonstructural Protein 5A Modulates the Toll-Like Receptor-MyD88-Dependent Signaling Pathway in Macrophage Cell LinesJournal of Virology, 2007
- Investigating Toll-Like Receptor Agonists for Potential To Treat Hepatitis C Virus InfectionAntimicrobial Agents and Chemotherapy, 2007
- Changes in Gene Expression during Pegylated Interferon and Ribavirin Therapy of Chronic Hepatitis C Virus Distinguish Responders from Nonresponders to Antiviral TherapyJournal of Virology, 2007
- Differential dysfunction in dendritic cell subsets during chronic HCV infectionClinical Immunology, 2007
- Monocyte-derived dendritic cell function in chronic hepatitis C is impaired at physiological numbers of dendritic cellsClinical and Experimental Immunology, 2007
- Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2Proceedings of the National Academy of Sciences, 2007
- Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virusNature, 2005
- VISA Is an Adapter Protein Required for Virus-Triggered IFN-β SignalingMolecular Cell, 2005
- Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3Cell, 2005
- IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon inductionNature Immunology, 2005